TRIUMEQ 50 mg/600 mg/
As listed in the register: TRIUMEQ 50 mg/600 mg/300 mg, comprimé pelliculé
300 mg + 52,6 mg + 702 mg · comprimé pelliculé
- Prescription only
- Active substance
- Lamivudine + Dolutégravir Sodique + Sulfate D'abacavir
- Made by
- VIIV HEALTHCARE (PAYS-BAS)
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | VIIV HEALTHCARE (PAYS-BAS) |
|---|---|
| Active substance | Lamivudine + Dolutégravir Sodique + Sulfate D'abacavir |
| Strength | 300 mg + 52,6 mg + 702 mg |
| Form | comprimé pelliculé |
| Route | orale |
| Dispensing (as stated by the register) | prescription initiale hospitalière annuelle · liste I · renouvellement non restreint |
| Marketed | Yes, according to the register |
| Authorisation procedure | Procédure centralisée |
| EU number | EU/1/14/940 |
| Name in the register | TRIUMEQ 50 mg/600 mg/300 mg, comprimé pelliculé |
| Packs | 1 flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 30 comprimé(s) |
| CIS | 64287253 |
| CIP13 | 3400927948954 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.
See every product with Lamivudine + Dolutégravir Sodique + Sulfate D'abacavir